Risk Factors Associated with HCV Among Opioid-Dependent Patients in a Multisite Study

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of community health

• Publication date

  2015-03-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10900-015-0016-2PMID 25814381PMCID PMC4558248
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Uptake of hepatitis C treatment among people who inject drugs attending Needle and Syringe Programs in Australia, 1999–2011

  2014cited by this paper
• Buprenorphine/Naloxone and methadone effects on laboratory indices of liver health: a randomized trial.

  2013cited by this paper
• Hepatitis C infection in non-treatment-seeking heroin users: the burden of cocaine injection.

  2013influential reference
• The Impact of Ethnicity on Hepatitis C Virus Treatment Decisions and Outcomes

  2013influential reference
• Testing for HCV Infection: An Update of Guidance for Clinicians and Laboratorians

  2013cited by this paper
• Integrating Phylodynamics and Epidemiology to Estimate Transmission Diversity in Viral Epidemics

  2013cited by this paper
• High prevalence but low awareness of hepatitis C virus infection among heroin users who received methadone maintenance therapy in Taiwan.

  2013cited by this paper
• Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: ETHOS study.

  2013cited by this paper
• Vital Signs: Evaluation of Hepatitis C Virus Infection Testing and Reporting — Eight U.S. Sites, 2005–2011

  2013cited by this paper
• HCV Infection Prevalence Lower Than Expected among 18–40-Year-Old Injection Drug Users in San Diego, CA

  2013cited by this paper
• [Study on the incidence and risk factors of HCV infection among heroin addicts who were on methadone maintenance treatment in Dehong prefecture,Yunnan province].

  2013cited by this paper
• The rising prevalence of prescription opioid injection and its association with hepatitis C incidence among street-drug users.

  2012cited by this paper
• Evolving epidemiology of hepatitis C virus in the United States.

  2012cited by this paper
• Prevalence, Distribution, and Correlates of Hepatitis C Virus Infection among Homeless Adults in Los Angeles

  2012cited by this paper
• Estimating the force of infection for HCV in injecting drug users using interval-censored data

  2011cited by this paper
• Clinical practice. Chronic hepatitis C infection.

  2011cited by this paper
• Hepatitis C virus infection in USA: an estimate of true prevalence

  2011cited by this paper
• Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.

  2011cited by this paper
• Hepatitis and liver cancer: a national strategy for prevention and control of hepatitis B and C.

  2010cited by this paper
• The First Injection Event: Differences among Heroin, Methamphetamine, Cocaine, and Ketamine Initiates

  2010cited by this paper
• TOPIC HIGHLIGHT

  2009cited by this paper
• A meta-analysis of the hepatitis C virus distribution in diverse racial/ethnic drug injector groups.

  2009cited by this paper
• Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004.

  2008influential reference
• Critical issues in the treatment of hepatitis C virus infection in methadone maintenance patients.

  2008cited by this paper
• Referral for chronic hepatitis C treatment from a drug dependency treatment setting.

  2007cited by this paper
• Injecting and sexual risk correlates of HBV and HCV seroprevalence among new drug injectors.

  2007influential reference
• Minimal uptake of sterile drug preparation equipment in a predominantly cocaine injecting population: implications for HIV and hepatitis C prevention.

  2007cited by this paper
• Risk behaviors and HIV, hepatitis B, and hepatitis C seroprevalence among injection drug users in Georgia.

  2006cited by this paper
• Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies

  2006cited by this paper
• A cluster of acute hepatitis C virus infection among men who have sex with men – results from contact tracing and public health implications

  2005cited by this paper
• Is an assay for simultaneous detection of hepatitis C virus core antigen and antibody a valuable alternative to nucleic acid testing?

  2005cited by this paper
• Global epidemiology of hepatitis C virus infection.

  2005cited by this paper
• Hepatitis C virus infection: prevalence, predictor variables and prevention opportunities among drug users in Italy

  2003cited by this paper
• Detection of hepatitis C core antigen in serum or plasma as a marker of hepatitis C viraemia in the serological window‐phase

  2002cited by this paper
• Detection of HCV core antigen in human serum and plasma with an automated chemiluminescent immunoassay

  2002cited by this paper
• Reliability of Self-Reported HIV Risk Behaviors of Drug Users

  1995cited by this paper
• Validity of self-reported drug use among injection drug users and crack cocaine users recruited through street outreach

  1994cited by this paper
• Erratum to The MOS 36-item short form health survey (SF-36): I. Conceptual framework

  1992cited by this paper
• The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection

  1992cited by this paper
• Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

  1989cited by this paper

• Trends in HCV Prevalence and Risk Factors Among People who Inject Drugs in Los Angeles County, 2012-2024.

  2026cites this paper
• Severe bacterial infections in people who inject drugs: the role of injection-related tissue damage

  2022cites this paper
• Effect of HCV or HIV infection on mortality among hospitalized persons who used opioids, 2000-2010.

  2022cites this paper
• Opioid agonist treatment for people who are dependent on pharmaceutical opioids.

  2022cites this paper
• Women-Reported Barriers and Facilitators of Continued Engagement with Medications for Opioid Use Disorder

  2022cites this paper
• Factors Associated With Severe Bacterial Infections in People Who Inject Drugs: A Single-center Observational Study

  2022cites this paper
• A pilot study of a mixed-method approach to design an ED-based peer mHealth referral tool for HIV/HCV and opioid overdose prevention services.

  2022cites this paper
• Emerging Viral and Bacterial Infections: Within an Era of Opioid Epidemic

  2020cites this paper
• A systematic scoping review of research on Black participants in the National Drug Abuse Treatment Clinical Trials Network.

  2020cites this paper
• Hispanic participants in the National Institute on Drug Abuse’s Clinical Trials Network: A scoping review of two decades of research

  2020cites this paper
• Effects of Medication-Assisted Treatment (MAT) for Opioid Use Disorder on Functional Outcomes: A Systematic Review.

  2020cites this paper
• Epidemiology: Opioid Use and Related Disorders

  2019cites this paper
• Hepatitis C infection and psychiatric burden in two imprisoned cohorts: Young offenders and opioid-maintained prisoners.

  2018cites this paper
• Social disorganization theory and Hepatitis C incidence

  2017cites this paper
• Risk factors for hepatitis C seropositivity among young people who inject drugs in New York City: Implications for prevention

  2017cites this paper